Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients
- PMID: 34843810
- PMCID: PMC8626154
- DOI: 10.1016/j.jinf.2021.11.017
Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients
Keywords: Biomarkers; COVID-19; Calprotectin; Emergency medicine; Viral infection.
Conflict of interest statement
Declaration of Competing Interest Reagents for serum calprotectin measures were provided by Gentian AS. Gentian AS had no role in the design, performance or analysis of the study but reviewed the results and interpretation before presentation. All authors declare no conflicts of interest.
Figures

Comment in
-
A meta-analysis of the association between calprotectin and the severity of COVID-19.J Infect. 2022 Mar;84(3):e31-e33. doi: 10.1016/j.jinf.2022.01.022. Epub 2022 Jan 21. J Infect. 2022. PMID: 35074506 Free PMC article. No abstract available.
References
-
- Gupta Rishi K., Harrison Ewen M., Ho Antonia, Docherty Annemarie B., Knight Stephen R., van Smeden Maarten, et al. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med. 2021 doi: 10.1016/S2213-2600(20)30559-2. Doi: - DOI - PMC - PubMed
-
- Knight Stephen R., Ho Antonia, Pius Riinu, Buchan Iain, Carson Gail, Drake Thomas M., et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370 doi: 10.1136/bmj.m3339. Doi: - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical